Libo Pharma Company Description

Libo Pharma Corp., a clinical-stage biopharmaceutical company, engage in novel therapeutics development in the field of oncology and hematology.

The company offers LIB-101, an interleukin-12 (IL-12) cytokine immunotherapy for innate immunity, adaptive immunity, and hematopoiesis.

Libo Pharma Corp. was founded in 2017 and is based in Taipei, Taiwan.

Libo Pharma Corp.

Country	Taiwan
Founded	2017
Industry	Pharmaceutical Preparations
Employees	31

Contact Details

Address: 9F - 1, No. 36, Nanjing West Road Taipei, 103614 Taiwan
Website	libopharma.com